From: Subject: Medical News Today News Article Date: Fri, 20 Feb 2009 23:36:49 +1100 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_000B_01C993B4.19DEFBD0" X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.5579 This is a multi-part message in MIME format. ------=_NextPart_000_000B_01C993B4.19DEFBD0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Content-Location: mhtml:file://C:\Documents and Settings\Clive\My Documents\Pollution Linked To Deep Vein Thrombosis And Blood Clots.mht =EF=BB=BF Medical News Today News Article
3D"Medical 3D""=20

Pollution Linked To Deep Vein Thrombosis And Blood = Clots

13=20 May 2008   

New=20 research on people living in Italy, suggests that long term = exposure=20 to air pollution is linked to an increased risk of deep vein = thrombosis and blood clots in the legs or thighs, adding to = previous=20 research findings linking particulate air pollution and = increased=20 risk of death from cardiovascular diseases.

The study = is=20 published in the May 12th issue of the Archives of = Internal=20 Medicine and is the work of Dr Andrea Baccarelli, from = the=20 Harvard School of Public Health in Boston, US, and = colleagues from=20 other research centres in Italy and the US.

Air = pollution=20 comprises small particles and fine droplets of chemical = matter=20 produced from burning fossil fuels and other sources. = Previous=20 research has linked increasing concentrations of particulate = air=20 pollution with increased risk of heart disease and stroke, = and=20 scientists have suggested this could be due to the particles = causing=20 blood coagulation and arterial thrombosis, wrote the authors = in=20 their background information.

Baccarelli and = colleagues=20 obtained data on 870 deep vein thrombosis (DVT) patients = from the=20 Lombardy region of Italy who had been diagnosed between 1995 = and=20 2005 and matched them to 1,210 controls who did not have = DVT.=20

Then they assessed the patients' exposure to = particulate air=20 pollution in the year before their diagnosis, and for = controls, the=20 year before their examination. They used measured mean = levels of=20 particles smaller than 10 micrometers in diameter (PM10) = obtained=20 from pollution monitors located in 53 different sites within = the=20 nine geographic areas where the patients and controls=20 lived.

The results showed that:=20
  • Individuals with DVT tended to have a higher exposure = to PM10=20 air pollution particles than controls.
  • There was a significant link between higher mean PM10 = particle=20 levels and shortened prothrombin time (PT, a measure of = blood=20 clotting tendency) in DVT cases .
  • After adjusting for other environmental and health = factors,=20 for every increase in PM10 concentration of 10 micrograms = per=20 cubic metre in the year before diagnosis, the risk of DVT=20 increased by 70 per cent.
  • The link between PM10 level and DVT risk was stronger = in men=20 than women, and went away among women on oral = contraceptives or on=20 hormone therapy.
On the effect of hormone = therapy and=20 contraceptives, the authors wrote that "Such hormone = therapies are=20 independent risk factors for deep vein thrombosis, which is = also=20 confirmed in this study by the higher prevalence of oral=20 contraceptive and hormone use in the cases compared with the = controls."

They concluded that:

"Long-term = exposure to=20 particulate air pollution is associated with altered = coagulation=20 function and DVT risk. Other risk factors for DVT may = modulate the=20 effect of particulate air pollution."

They said their = findings "introduce a novel and common risk factor into the=20 pathogenesis of deep vein thrombosis," and add weight to the = case=20 for tighter controls to reduce urban air = pollution.

In an=20 accompanying editorial titled "Blood Clot Risk Could = Increase=20 Estimates of Death Toll from Pollution", Dr Robert D Brook = of the=20 University of Michigan, Ann Arbor, wrote that air=20 pollution:

"Has become so omnipresent over the past = century=20 as to be commonly perceived as a normal natural entity - the = lazy,=20 hazy days of summer."

But he adds that, "While we = have=20 learned to live within this haze without a second thought, = air=20 pollution is neither natural nor benign."

Although at = any one=20 point in time the absolute risk to one person's = cardiovascular=20 health posed by particulate air pollution is minute, it is = the=20 constant, ubiquitous nature of the exposure that places it = at 13th=20 place among the world's biggest killers, accounting for = around=20 800,000 deaths a year, wrote Brook, who added that this = study sheds=20 light on a new risk posed by air pollution.

"If = future=20 studies corroborate their findings and address some of the=20 limitations, it may be proven that the actual totality of = the health=20 burden posed by air pollution, already known to be = tremendous, may=20 be even greater than ever anticipated", he=20 concludes.

"Exposure to Particulate Air = Pollution and=20 Risk of Deep Vein Thrombosis."
Andrea Baccarelli; = Ida=20 Martinelli; Antonella Zanobetti; Paolo Grillo; Li-Fang Hou; = Pier A.=20 Bertazzi; Pier Mannuccio Mannucci; Joel Schwartz
Arch = Intern=20 Med. 2008;168(9):920-927.
Vol. 168 No. 9, May 12,=20 2008

Click here for=20 Article.

Sources: Journal abstract and = JAMA=20 press release.

Written by: Catharine Paddock, = PhD=20
Copyright: Medical News Today
Not to be reproduced = without=20 permission of Medical News Today


Article URL:=20 http://www.medicalnewstoday.com/articles/107178.php

Main News Category: Water - Air Quality / = Agriculture

Also Appears In:  Blood / Hematology,=20  Vascular,  

3D""=20=20
3D""=20=20
Save time! Get the latest medical news = headlines=20 for your specialist area, in a weekly newsletter e-mail. See = http://www.medic= alnewstoday.com/newsletters.php=20 for details.
Send your press releases to =
------=_NextPart_000_000B_01C993B4.19DEFBD0 Content-Type: image/jpeg Content-Transfer-Encoding: base64 Content-Location: http://www.medicalnewstoday.com/images/title_printerfriendly3.jpg /9j/4AAQSkZJRgABAgAAZABkAAD/7AARRHVja3kAAQAEAAAAPAAA/+4ADkFkb2JlAGTAAAAAAf/b AIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoKDBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxsc Hx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f Hx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgAMgFMAwERAAIRAQMRAf/EAKcAAQABBQEBAAAAAAAAAAAA AAAFAQIDBAYHCAEBAAMBAQEBAAAAAAAAAAAAAAECAwQFBgcQAAEDBAEDAgQEAwUIAwAAAAIBAwQA EQUGEiETBzEUQVEiMmEjFQhxQlKBkdFiM7GCklOUFlYXgyQ1EQACAQIEAwUGAwcFAQAAAAAAAQIR AyExEgRBURNhcZEUBYGx0SIyBvBCUqHB4XKSogeCwiMzJBX/2gAMAwEAAhEDEQA/APn2v008cUAo BQCgFAKAUAoBQCgFAKAUAoBQCgFAKAUAoBQCgFAKAUAoBQCgFAKAUAoBQCgFAKAUAoBQCgFAKA+n PHuja/E8F5JjJRI72x5vEZPMxCeaFx1hgWkaYMDVOQJ1BwbeqktfJ77eT80nFvRCSXfz+B3Wra0Y 5spl9HwGu/tyycGRCju7RDgxpuRfJoSfYcmyBcFvuKPIVAE42Rfx+NZrfTnulKr0V9yJ6aUKcTz3 HeINUxuG16VvOwP4rJ7RxLGYyLG7xg0aigG+Sr9N+4PS3S/xstvTl6rNuStxTUc237jFWVhV5mzG /b6MfZNoZz2cDG6tqpNJMzStKRO99oH2wBtFWxdt0eXVeqoiIt6mXrNYRcY1nPgPL4urwR0mf1TR MJ4RYa1iSmec2/MMQ8VlpEXtSU5OILgMo6AuCN4pJe3838K4VvrktxWfy6I5J4fjE06aUMOJm3Hx AxnNyexsvIY/D61puJYLMZeJC9sqk4hGgmHdd7jnaBCI1JLX+35tv6m7cKpOU5ywTdROzV9iPLs/ r3ihvM4SFrWzzMzFmPqGWfSC8Bx2UIEQm2zACcJUUugovpXqWd7ecZOcVFpYY5mMrcaqjOoz3hnS 2/HuZ27BZ6e6OHIBNrIQTio4ZkA8B5oBde4llRF61z2/VrnVUJxjjydSzsLTVMt82QMZrnj7x7r7 UNhrLPwlyGUkC0AvqRgHETcRORJyccTqv8qVTY7iU79yVXprRFrkKRSJT9qut4edlM/mc3Hjv46F HYiikwGzZR2S7dFs4ipyTtWv/m/Gp9d3EoxjGLabxw7CNtFNts6GZ45i6ThPKs57GtSW5T7UHV23 GgcUSnJZv26EhLyApgD0/orh8/K7K0q0p9Xs5+Bp0lFM5aL4H02PsON0vNbS8zu2RY7yw40TuxmS VsnEbN3l9S8QX5X/AA6V2v1i5pc4wWhduJn0FWjeJB5TwsTOk4fLY+U7KzuSzp6+5A4p2ReB2Qzz FxPq4qscV6p0v+FdEPVk7ji1SCjqr4fEq7GHbU6DL/tzYheTMNqUfIvvwJsB3IZHJEAh7dtlSElT 7htyQE6/1fD1rGHrVbMptLUnRLmWe3+ZI1pXhrx7h9bj7LsWzzIuIyjziYc48In1KMJKjbrxByEV dGxInT1T1W9n/wBa7KWiMVVZ48R0ElVs8kzYYVvLy2sJIdlYptxRiSXx7bjgJ/OQJ9t1+FexYuyl FOWEjnkqPA0q3KigKXqKg6bx5p6bZsrWMek+xxzTTsvKZBUuMeKwCm44t7J8hS/xWuXebnow1JVe SXNmluGp0NPdNYk6vs07CvmjyRjvHkj9rzDiIbLw2v0cbJCqdtuVdgpLj7yJw0uhCotdKZQrUgUA oBQCgFAKAUAoBQCgFAKAUAoBQCgFAKAkdbxsXJ7BjsfMlNwYkqS01JmPmLbbLRGiG4RmqCnEbr1r K/Nwg5JVaRaKq6H0hr3lDUx8/wCXR/Kw4uo47AJisY+UhpYhoybDtgPkokq3cRERVVbf3fHXdtPo LB63Kr5nfGa1dhz2M8k4HYvHXlHJZjIRo+Szk7nExrshtuS5DZbaFltpszEjUWxUfp9VqHt5RnBJ YIak0zs923BM3Oi5PTvLeH1zADFbBzGmsdXhISJSMWT/ADb8CFOFk9LVjat0wlbcmWk+TOMh53Wt z8JZXEZHdYuNzsjKu5DJv5QxB6S20aK1ZpFEju023xRtFso8bV1StytXk1GqpwKJpxzJiZk9DY3H xVrDGx4x7XtVjOzpuTSXG7JS2m07XMu4QAavN8uPL+b42rJRm4zlpeqXChaqqkY2dv1DetU8ha+/ tEHXcxms2483LmuADTsJhWAjoLqmIkJNRuP0l/ZZep2p25QlpbSQqmniaPiXFePNNmbTBjbxiF2Z zHNNY3YHSaCKw893u4kdxw+DvGzKkqL+Fui333U5zjF6HpriueWf7SkEk3jiXbhsmKmeNNX1Cdus TYJmZzrSZ7JnMBUahC8S8nBI+bTaCgKnO3otZQg+pKajposFQs3hSp55+4zaYOx+U5TuOlNTcZAj R4kKTHcB5kgQO6XA21IbI46Setel6TZcYKqxMb8qsmYew4jX/wBtkyHAycb/ALj2DKAUiI0+37xl ho04qTSF3BH/AOt62/n/ABqN7CU91inpjH2fjEm20oHou2+cNTy2J8ZyJc+Oqv5OLkNhYAxcOKUM FRe80FyAfcOIY3RLoN0ryY7ScXNU4YG7mnQxeQdvzQS8vnsP5gxjeE4G/BwkNYr8zo3cGAFORciN Lcl9L3WrWLSdIu268yJS41I/xx5P1bAeB1nZKfEkbPiJUyXjMc6+BynJj5GDTpMKvcJLySVVt6XK r7rbT61EnpaREJrSZvJnl3Ah4ixJYrJxpm67HioeMyDjMkHnorJNI5LR7iSq0RGagvKy3X/LWdix LqYr5U6kykqEl46nt6KIRcv5WwGY0uE06P6QLkd+QraiSALfEjd9VReCKSW6IlTuIu5irclPmIun HA+Zc5Oi5TY8tPxsb28KZMkSIkUBREaZddI2wQR6IgiSJX02zlpgtTOO4qs1fbyf+Uf/AArXZ1o8 14melnqegQtX0zDQ9q3TGt5E8++kPFYmQiLwgoaJMnkCp8E+hr0ut19OteVu7s70nbtOmlVbXPhH 4m8IqKq+Jw2+6y5q235TBmvNuI8vtnei9yOaIbDnTp9bRCtd213PVtqXP38TOcKOh0sZf+1vD8iW v0Zbd31ix1/mHFwSQniRUW6d6RYPxQa5Jy6u4S/Lax/1P4F0qQ7y+ehbr4vjZJtFd2LS0CDPFOpv Yl0l9s7a919u4qtrZOgqirVIS6N5r8lzFdkuPiS1qj2o4KPiss+KkzCfdFFspA2ZJf5dEr0lfjzX iY6WY3mH47pMyGyZdG3JtwVEkul0ui9fSuiMk1VFWiyrECgFAKAUAoBQCgFAKAUAoBQCgFAKAUAo CipdKhqoLO0NY9BFtRTsjUeXROsp7cap5WJOsqrAqlWe3TI1lEjilQtqkNZXsDUvbRGsp7cbVHlU NYSOKVC2qROs9G1bwZsGw4hvKQstiGQNr3DsZ+S4j7LfWxPADTiAionLqvpXxPqf3ztPT77szs7i TUtKlGC0yfKLc1XllmddvZynGqcfEMeDtgl5ORFjZXFSIcJgZGQzDUklgsIakiAbqgP18QUlREsi WuqXpuPvraRtRnO1fjcuScYWnD/klSmKjq+mronXF1onQR2cq0TjRceBHbt4lzGr4iJm1mwsthZh 9pnIY91XW+aoSoirZPXgXVLp0rq9D+6dt6jfnt9FyzfgquFyOl0w+KwdGVvbeVtKVU4vkTh/tz2R vIMY53PYJnJyQRxjHOS3QkmK3soskyhr9q/D4V4kf8g7N23ejY3TtRdHNW4uCf8AMp04rxNvJTrT VGvf/A4xjRc5I3IdQRoRzCylhkKqqtiQr9RqQoS8BFOSkifb1r6696xtY7DzzdbGjX2tcFjT5m8K VzwOVW5a9HGpMZnw9n8Pu2N1CZLgjkco2DkZ8XHVjp3DNsBIlaQ0JSaVPs+VeTsfuvabnYXN9bhc 6VltSVI6sFFtpaqUpL9XM1nt5xmoNqrMeP8AEexTstn8eb0WGGtIZZSfJNwYwoBKicTBsyXmIqQ3 FLonz6Vpu/ujZ27O3upTm91Tpwio68eacksHRPHN8sSIbebclgtOZz+C2PPa5KObg57+OluNqyb8 Y1bNWyVCUFUfgpAi/wBlfT3tvBwpJVVTnjJ1wJ3/ANyeU/8AynJf9Q5/jXH5Kx+hF+pLmc9ndkz2 fmpOzU9/Iy0BGxfkuE4SAKqqCikq2S6r0re3bjBUiqIq23mekT8JM8h6npeSx4oeZYkN6plF6fBe cF4kTrx7KkJEv9NcMLqsTmn9P1r96NXHUl4HOeXs9CyW3nAxRXwevst4fEp0VFZiJwJy6Wv3XOR3 +N632UHG3V/VL5n7Stx1fcc5gNkz+vTCm4PIP46WYK0b0Y1bJQJUVRVR+FxRa6LlmNxUkqoopNZH Qf8AuLyn/wCU5L/qXP8AGs1sLH6ET1ZcyAyuYyuZnu5LKynZs9/j3pT5Kbh8BQB5EvVbCKJXpWLc YQUYqiMpNt4mnWjKlakCgFAKAUAoBQCgFAKAUAoBQCgFAKAUAoBQCgFAKAUAoBQFFqGSew6Iia/4 L3DPl9MjMuDjIy/FQsjaqi//ADuf8NflX3E/O/cWz2y+mwndl3/V/sj4npWPksSlzwMmSbew/wC2 vFNQWyJzYsipT3GxVUVENziKqnxX27Y/31jtpx3P3XdlceG2tfIn3Rq/75PwJktO2VPzM6Adedh6 l410CaKjkcnkkymRir94R2lN9wCS30rwct/EV/GvDfqau731H1O3/wBdqz0oS4OT0xTXPGPg12G3 TpC3bebdS6BBn7L+5KbljacHEa+pIcgxUW09sz2UHmqcbq+Sl/C9V3G5t7H7WhYTXW3FMOPzy1ZZ /RRd9CYxc9y3wiUxMOI01s2+yMrCwuV2t6VH1aTkXO0LcPnxKQKIilzILcbJ8l9Cqd3uJye29Nja uX7O0jCV+NtVrOlVB8NKeftWcRGK+a5VJyrSvIg/Prk6Ht+mzIhi/MagRijPtL0ceaeUhUF6LZSV FT+Net/j1W7mx3lua0wldnqT4RlGjr7MzLfVU4tZ0M/7jNoDHyi1XFgkb9SUMlnnG16vOqiA02S/ gjSEv+7+NYf419Kd6C3l56ulW3ZT/LHOTX9TS9vYW39yj0Ljizwhbr61+uurPLCDTSKleNToFTrd D8m7HpDOWaxHaVMvH7DiuoSq0aISA+1xIbOtoZcVX5+lce62UbrWr8v4oaQuOJyNlVbr611KJSp6 Kx4viS4EiRDlOm68zjXcO0qCqurKFpZgn0T/AECf6cflXJ5tppNfqr7K08aF9BnDxlgZj0hzHznz goxPCIZ8FJydGme3itXQUSzrbjTipa/r19Kh7ucUqpVrHwaq/DEaEY4/jnCG6LZTX09g5AXOW4fl syMc5Pkk39Pqysdxvrf4XrTzk0ss9Wn2S0rxqmR00Qm66jH1v2rCvG5NeenIYlx4diNKOIyY2Trz Nhzr6fKura7h3avhh4tVfvRScaHYS/G+hxpuRjlKyhfpGSx+NlKnt/zf1IHFEm+n0dpWVvfly+Q3 unJHeXmk6R+aMnx/LT3l3biY4HiLFrHkLkMgTSnOyMGJLV6Iwy1+nrwF19t8xccR1xbcWvtTrdb2 q0/UJVVFwi8m/q5U5doVpFsHV9cxet59s1ek50tXi5QydBso7aTZUN0Oz05g4206IqV/q5F6W6zK /OU48IdRx7cFLMKKSfOhbtema1jsxm5menSkYPOTMREeissBwKMAOuPustgAKP57aI20IfG3ypY3 M5RioJfQpOtePCvseLqRKCTdeZot+PcS9pEvMgU1mdExzeT7khGW2H0OSEc22WFVJBAHdT89Lgqp bpdK0e7krqjhRypxqsK4vL2ZkdNaanWZvx1qWT3ia1JOVDdy+1T8HBZhCyEdgWgYNtxRIb2QpFlA bXT4pbrx2t5cjaVKPTbjJ1rV5/A0dtOXtoctD8a4wtMay8yYTE6XjZWVimT8UGBSM46ARyYM0kOG 97cuJAlkVRSy9bdct7Lq6UsFJRyfGmNcsKmatqlSQb8Q4uS8oRZzypIyEJuEpcP/AM2UMMjkOdE6 j+qMWXoPrWb9Qklisouv8y1Yf2st0l+Px2kY/pmmBrS5qPKnTmWwCS+7HVkgbQpnZ9m+Aibsd1Wf rF5wUbIuiD1rVbm7r0tJcOPKtVzVeCxK6FSpO7bpOmubrsL7gycfi0zwYSJEhCyiNvv9wjdQeAij LSAnFpEut/uS1c+33N3pRWDlo1Y1y+L5l5QWp95brGi4HC5JhnLG5LzMuDsDkdpAbOGgwGJkVOYm nPn3I5uCSL9Nh6dbpN/dTnFuOEU4d+Li/wB9CIwSePaRi+O9cb1j9ZkO5CMEQcbIlm+jDffjzjEH ijx1/PAW1P8ALdJCE7X+Na+cn1NK0uuqmeDWVXl3rgR01SpA7tprGsNsMOPG5kHZmQaIVt2/axH/ AGzLo2S69xxt3re1kS1b7bcu7V8KR8Wqv9xWcNJMO+PdbLaIeos5CS3nRlR4+QecbAo5A40rshxh BsQ9hfpQTVefrcfSsVu59N3Gloo6c+yvf+wnQq04l8PQ9TmQ0zjcieGELGTZwxy7KykfgPtNE2p8 UbUHBeEkLj9N/jbrEt1cT0Ujq1JcaYp/AlQWfAt2TQtXh4XJTcZKmlIhwsVlGwko1w7GVBskZLh1 U2+6i8+iL6cUtdZs7q5KSUkqNyjhzjxIlBUw7DzyvRMhQCgFAKAUAoBQCgKLVWSS8jcdjf1ePqzk u+Ciuq+xDRtobOKpkpK4go4XVwvuL/YleNH0Taw3kt4of+icdLlWWWC+mulfSsl72a9aTjor8pKa p5a33VYC47D5LtwOSmMZ1tt4QIluSh3BJRuvWyLb415PrH2h6d6hd6t+3W5lqTcW++jx95ra3VyC ongaY+Sd3HaE2lcoZ50QJsJjjbTnACRUUQbMCbEbEvQR+NbS+2dh5TyfSS29a6U5Kr5tp6m8Fmx5 ierVX5iRy3mvyhloD0CdnXCivioPA0zHYUhJLEKmy22VlT1S9cG0+yPSdvcVy3YWuOKrKcse6Umi 8t3dkqNkBsW37Fsaw/1iX7lMeykaGCNtNC20PoIi0ID/AG2vXsem+j7bZa+hHT1JapYyk3LnWTbM rl2U6VeRs5Pfdsyk7FTp85HpWERtMY4rLA9pGiQgTiIIJ2UU+9FrLafb+z29u7btw0wv11rVL5tS o85VWf5aEyvzk028sjS2LY81seVcyuZke6yDwiLj3Btu6AKCP0tiA9ET5V2+memWNlZVmxHRbVaK reeLxk2yly5Kbq8yPRK9JIzKolXSIqVtVqEFFGquJNQg1CiKnWYnyVsuLTBJFVi+ujKHHkQKqr7z 71cVCTkoLZQ/pslc89jblqrX56V9hZXGqdhq4jeM3isTGxcTtJGiZNrMMkQXNJLQiiJyv9hdsFIf iopWtzawnJyebjp9hCm0qFzW9Z1qZn5Q9rubI281PRQVUFHyUiVnr9CohECev0qqVD2kGor9GXsG t49pZmtyyeaJw8gxGddKGxAbdVteTQRzE0NpVJeLhqK8y+PIvnVrW2jD6a5t+Ic2zYk+Qs9Ik5CQ 4LHcyc2HkZNgJE70BHEZ4/V0H84uSfGqx2kEksflTXjmOozOz5N2Jr3Jo3FKS7JlzI0o2uTsR6el pBRiUvp5p/UhcfVLL1qHsoOmdKJd9Mqk9RmNfIuaXBPYgo8QkkQW8W9PVpfdFEZdB1ptXOVvoVsR T6ft6LeyWeTjr1VeeqnCpHUdKGyPlfaEnz56hFKVNmuZRpwmlVYsx4eBvRrl9JcbJ9XJOiL6oi1X yFuiWNEtPeuTJ6rMAeSMymHPGHEhOi7j/wBJdlmyvuCiCSG0CmJD/pEIqKonWycuVqt5OOrVV/Vq 7K/xHUdKGVzynszmYj5Yhje6jZh7PNojZcPdyBaE0VOX+naONhv8+tQtjb0uONHHT7FX4jqOte2p pRt8zUfBJiWwjr24z0BieTV5TcOSZOPRwcvbgZOH6jdEIkRURavLaxc9WOdacKrJka3ShtR/J+zx whg2rCeyxruJZXgt1Ydt9ZWLq4HAOJfDiPTpVXsbbrnjLV+OwnqM13d/zbmBLEE1GTnEbxzs9GrS jhNOi83HI78eAm2PXjysiJe1WW0ip6sc604VyqRrdKG8flXYHMrMyTsSA69OkMz3mjYUmknMcuEs AU+jv5hXT7F+I1n5CGlRrLBUz4Ph3ftJ6rrUw43ydsMGJ2Vaiy3xCa01OktKchtvIiSSQA0IUsRO EXpdFVfgqosz2UJOuKywWXy5BXGi5zyNk52Pdxc+PDRifHiwchPGOpSTZh8BjuKqGFzZBtES1kL+ a69aLZxi9SbwbaVcMc/EdRvAbturWZy5nHbGZEaxkbExpMxkRetHQCckiIkSNuuvCZeq/SaovVb0 2220Rxwepyw7eHcl7hOdWWu+UNqMojrRMRpcaRGmOy2WkF2S/CbVqO5IupCfACJLWRFuqkiqt6LY 28c2mmqck86DqMwyfIOZdB1hmPEiQjgvY4IUdsgZbakOi86QIpEXMzFFUiJfl6IlrR2kVi2261r3 YEa2YJm75mXClQ3RZ7UyFAxzvEFRezjBAWLLy+6zScl+P4VaO1imnycn/VmHNnP10FBQCgFAKAUA oBQCgKLVWSWrVGSWrWTJLaoySlVJFSCqVJBVKuiC9K0RBVKuiCtWIC0JCVAK1JAqQKAUAoBQCgFA KAUAoBQCgFAKAUAoBQCgFAKA/9k= ------=_NextPart_000_000B_01C993B4.19DEFBD0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.medicalnewstoday.com/images/blanktab.gif R0lGODlhAgACAIAAAP///wAAACwAAAAAAgACAAACAoRRADs= ------=_NextPart_000_000B_01C993B4.19DEFBD0 Content-Type: text/css; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medicalnewstoday.com/css/pagelayout.css BODY { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 78%; BACKGROUND: = url(/images/backgroundgradient.jpg) #d1d8e0 repeat-x left top; = PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #333333; PADDING-TOP: 0px; = FONT-FAMILY: Arial, Helvetica; TEXT-ALIGN: center; TEXT-DECORATION: none } #wrapper { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: 0px; = MIN-WIDTH: 1000px; PADDING-LEFT: 0px; FONT-SIZE: 100%; Z-INDEX: 1; = MIN-HEIGHT: 2300px; PADDING-BOTTOM: 0px; MARGIN: 0px auto; BORDER-LEFT: = #999999 1px solid; WIDTH: 1000px; PADDING-TOP: 0px; BORDER-BOTTOM: = #999999 1px solid; POSITION: relative; HEIGHT: auto; BACKGROUND-COLOR: = #ffffff; TEXT-ALIGN: left } * HTML #wrapper { HEIGHT: 2100px } #maincontent { MARGIN-TOP: 50px; FONT-SIZE: 105%; MARGIN-LEFT: 185px; WIDTH: 815px; = POSITION: relative; HEIGHT: auto } #maincontent_norightbar { MARGIN-TOP: 50px; FONT-SIZE: 105%; MARGIN-LEFT: 185px; WIDTH: 815px; = POSITION: relative; HEIGHT: auto } #forumcontent { MARGIN-TOP: 50px; FONT-SIZE: 105%; MARGIN-LEFT: 185px; WIDTH: 815px; = POSITION: relative; HEIGHT: auto } #maincontent { WIDTH: 490px; MARGIN-RIGHT: 320px } #forumcontent { WIDTH: 490px; MARGIN-RIGHT: 320px } #forumcontent { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; = PADDING-TOP: 0px } #rightcol200 { PADDING-RIGHT: 7px; PADDING-LEFT: 20px; FLOAT: right; WIDTH: 245px } #rightcol380 { PADDING-RIGHT: 20px; PADDING-LEFT: 20px; FLOAT: right; WIDTH: 380px } #leftpad100 { PADDING-LEFT: 100px } #leftmenu { PADDING-LEFT: 0px; Z-INDEX: 3; LEFT: 10px; WIDTH: 159px; POSITION: = absolute; TOP: 145px; HEIGHT: auto; TEXT-ALIGN: left } #menu { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; Z-INDEX: 1000; BACKGROUND: = #b3b1c0; PADDING-BOTTOM: 0px; WIDTH: 159px; PADDING-TOP: 0px; POSITION: = relative } #menu A { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: = #ffffff 1px solid; DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 11px; = Z-INDEX: 1001; BACKGROUND: #e2edf1; PADDING-BOTTOM: 5px; BORDER-LEFT: = #999999 1px solid; WIDTH: auto; CURSOR: hand; COLOR: #0f4c78; = PADDING-TOP: 5px; BORDER-BOTTOM: #999999 1px solid; HEIGHT: auto } #menu A:hover { BACKGROUND: #eeeeee; COLOR: #c60 } #menu A:active { BACKGROUND: #ccc; COLOR: #060 } #menu UL { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: 100%; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } .menuarrows { PADDING-RIGHT: 2px; FLOAT: right; POSITION: relative } * HTML #menu UL LI { FLOAT: left; HEIGHT: 1% } * HTML #menu UL LI A { HEIGHT: 1% } DIV#menu LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; = PADDING-TOP: 0px; POSITION: relative } DIV#menu LI:hover { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; = PADDING-TOP: 0px; POSITION: relative } DIV#menu LI UL { DISPLAY: none; LEFT: 100%; WIDTH: auto; POSITION: absolute; TOP: -100px } DIV#menu LI UL.csub { TOP: -10px } DIV#menu LI UL.sub2 { TOP: -122px } DIV#menu LI UL.sub3 { TOP: -142px } DIV#menu LI UL.sub4 { TOP: -162px } DIV#menu LI UL.sub5 { TOP: -182px } DIV#menu LI UL.sub6 { TOP: -202px } DIV#menu LI UL.sub7 { TOP: -222px } DIV#menu UL UL { BORDER-RIGHT: #dddddd 5px solid; BORDER-TOP: #dddddd 5px solid; = BORDER-LEFT: 0px; BORDER-BOTTOM: #dddddd 5px solid } DIV#menu UL UL { DISPLAY: none } DIV#menu UL UL UL { DISPLAY: none } DIV#menu UL LI:hover UL UL { DISPLAY: none } DIV#menu UL LI:hover UL UL UL { DISPLAY: none } DIV#menu UL LI:hover UL { DISPLAY: block } DIV#menu UL UL LI:hover UL { DISPLAY: block } DIV#menu UL UL UL LI:hover UL { DISPLAY: block } #menu A.x { BORDER-LEFT: #999999 1px solid; BORDER-BOTTOM: #999999 1px solid } #menu A.x:visited { BORDER-LEFT: #999999 1px solid; BORDER-BOTTOM: #999999 1px solid } #menu A.x:hover { =09 } #menu A.x:active { BACKGROUND: #ccc; COLOR: #060 } #menu A.c { BACKGROUND: #ffff99; BORDER-LEFT: #999999 1px solid; BORDER-BOTTOM: = #999999 1px solid } #menu A.c:visited { BACKGROUND: #ffff99; BORDER-LEFT: #999999 1px solid; BORDER-BOTTOM: = #999999 1px solid } #menu A.c:hover { =09 } #menu A.c:active { BACKGROUND: #ccc; COLOR: #060 } #menu A.z { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; BACKGROUND: #ffffff; = PADDING-BOTTOM: 1px; WIDTH: 200px; LINE-HEIGHT: 15px; PADDING-TOP: 1px; = HEIGHT: 15px } #menu A.z:visited { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; BACKGROUND: #ffffff; = PADDING-BOTTOM: 1px; WIDTH: 200px; LINE-HEIGHT: 15px; PADDING-TOP: 1px; = HEIGHT: 15px } #menu A.z:hover { PADDING-RIGHT: 0px; PADDING-LEFT: 10px; BACKGROUND: #ffffff; = PADDING-BOTTOM: 1px; WIDTH: 200px; LINE-HEIGHT: 15px; PADDING-TOP: 1px; = HEIGHT: 15px } #menu A.z:hover { BACKGROUND: #eeeeee } #menucatlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; LEFT: 1px; FLOAT: left; = PADDING-BOTTOM: 0px; MARGIN: 0px; OVERFLOW: auto; WIDTH: 158px; = PADDING-TOP: 0px; LIST-STYLE-TYPE: none; POSITION: relative; TOP: 1px; = HEIGHT: 180px; BACKGROUND-COLOR: #ffffff } #menucatlist LI { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 92%; FLOAT: left; = PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 98%; PADDING-TOP: 0px; = BORDER-BOTTOM: #ddf 1px solid; POSITION: relative } #menucatlist A { PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 5px; PADDING-BOTTOM: = 2px; WIDTH: auto; PADDING-TOP: 2px; HEIGHT: auto; WORD-WRAP: break-word } #menucatlist A:hover { BACKGROUND: #ccffcc; COLOR: #000 } #rightmenu { Z-INDEX: 3; RIGHT: 0px; WIDTH: 300px; MARGIN-RIGHT: 10px; POSITION: = absolute; TOP: 265px; HEIGHT: auto; BACKGROUND-COLOR: #ffffff; = TEXT-ALIGN: left } .rbtoparticle_star { FLOAT: left; WIDTH: 100px; POSITION: relative } .rbtoparticle_item { PADDING-BOTTOM: 2px; PADDING-TOP: 5px } #title { WIDTH: auto; HEIGHT: 215px; TEXT-ALIGN: left } #headerback { BACKGROUND: url(/images/bg.jpg) #ffffff repeat-x left top; WIDTH: auto; = HEIGHT: 162px; TEXT-ALIGN: left } #titleback { BACKGROUND: url(/images/topbg2.jpg) #002ab0 no-repeat left top; LEFT: = 50px; WIDTH: 922px; POSITION: relative; HEIGHT: 69px } #searchback { Z-INDEX: 1; LEFT: 446px; BACKGROUND-IMAGE: url(/images/adsbg.jpg); = BACKGROUND-REPEAT: no-repeat; POSITION: absolute; TOP: 69px } .top-menu A { FONT-WEIGHT: normal; FONT-SIZE: 15px; LINE-HEIGHT: normal; FONT-FAMILY: = "Trebuchet MS", Arial; TEXT-DECORATION: none } .top-menu A:hover { TEXT-DECORATION: underline } #titlebannernew { LEFT: 190px; POSITION: absolute; TOP: 155px } #login { Z-INDEX: 1; LEFT: 10px; WIDTH: 210px; COLOR: #aaaaaa; POSITION: = absolute; TOP: 80px; TEXT-ALIGN: left } .customerror { COLOR: #cc0000 } .custombig { FONT-WEIGHT: bold; FONT-SIZE: 16px } .photobox_left { BORDER-RIGHT: #cccccc 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: = #cccccc 1px solid; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 4px; BORDER-LEFT: #cccccc 1px solid; PADDING-TOP: 4px; BORDER-BOTTOM: = #cccccc 1px solid; BACKGROUND-COLOR: #ffffff; TEXT-ALIGN: center } .photobox_right { BORDER-RIGHT: #cccccc 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: = #cccccc 1px solid; PADDING-LEFT: 4px; FONT-SIZE: 11px; PADDING-BOTTOM: = 4px; BORDER-LEFT: #cccccc 1px solid; PADDING-TOP: 4px; BORDER-BOTTOM: = #cccccc 1px solid; BACKGROUND-COLOR: #ffffff; TEXT-ALIGN: center } .photobox_left { FLOAT: left; MARGIN: 0px 15px 10px 0px; POSITION: relative } .photobox_right { FLOAT: right; MARGIN: 0px 0px 10px 15px; POSITION: relative } ------=_NextPart_000_000B_01C993B4.19DEFBD0 Content-Type: text/css; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medicalnewstoday.com/css/default.css .blue_dark { COLOR: #003366 } .blue_sea { COLOR: #0f3f9f } .blue_sea_paddingtop { COLOR: #0f3f9f; PADDING-TOP: 10px } .red_dark { COLOR: #990000 } TD { FONT-SIZE: 80% } TD.rightbar { FONT-SIZE: 11px; BACKGROUND-COLOR: #eeeeff } TD.sideline { BACKGROUND-IMAGE: url(/images/blacktab.gif); BACKGROUND-COLOR: #000000 } H1 { FONT-SIZE: 17px } H2 { FONT-SIZE: 15px } H3 { FONT-SIZE: 13px } H2.sectiontitle { MARGIN-TOP: 4px } .smallwhite { FONT-SIZE: 75%; COLOR: #ffffff; TEXT-DECORATION: none } .smalltext { FONT-SIZE: 10px; TEXT-DECORATION: none } HR { BORDER-RIGHT: 0px solid; PADDING-RIGHT: 0px; BORDER-TOP: 1px solid; = PADDING-LEFT: 0px; PADDING-BOTTOM: 4px; BORDER-LEFT: 0px solid; COLOR: = #dddddd; PADDING-TOP: 3px; BORDER-BOTTOM: 0px solid; HEIGHT: 1px } .title { FONT-WEIGHT: bold; FONT-SIZE: 150%; COLOR: #000066; PADDING-TOP: 5px } A { TEXT-DECORATION: none } A:link { COLOR: #0000cc } A:visited { COLOR: #990099 } A:hover { TEXT-DECORATION: underline } A:active { COLOR: #009900 } A.nextpagelink { FONT-SIZE: 18px; COLOR: #0066cc } .menutext { FONT-SIZE: 11px; COLOR: #000000 } A.smalltext { FONT-SIZE: 90% } A.smalltext:hover { FONT-SIZE: 90% } SELECT { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = FONT-SIZE: 90%; BORDER-LEFT: #999999 1px solid; COLOR: #000000; = LINE-HEIGHT: 14px; BORDER-BOTTOM: #999999 1px solid; BACKGROUND-COLOR: = #ffffff } INPUT { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 1px; BORDER-TOP: = #999999 1px solid; PADDING-LEFT: 2px; FONT-SIZE: 95%; PADDING-BOTTOM: = 1px; BORDER-LEFT: #999999 1px solid; PADDING-TOP: 1px; BORDER-BOTTOM: = #999999 1px solid; FONT-FAMILY: Arial,Helvetica; BACKGROUND-COLOR: = #ffffff } INPUT.list { FONT-WEIGHT: bold; FONT-SIZE: 95% } INPUT.radio { BORDER-RIGHT: 0px; BORDER-TOP: 0px; FONT-SIZE: 95%; BORDER-LEFT: 0px; = BORDER-BOTTOM: 0px; BACKGROUND-COLOR: transparent } INPUT.submit { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = FONT-SIZE: 10px; BORDER-LEFT: #999999 1px solid; COLOR: #000000; = BORDER-BOTTOM: #999999 1px solid; BACKGROUND-COLOR: #ffffff } .box { BORDER-RIGHT: #dddddd 1px solid; PADDING-RIGHT: 5px; BORDER-TOP: = #dddddd 1px solid; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; MARGIN: 10px = 0px 0px; BORDER-LEFT: #dddddd 1px solid; PADDING-TOP: 5px; = BORDER-BOTTOM: #dddddd 1px solid; BACKGROUND-COLOR: #f4f4ff; TEXT-ALIGN: = left } .box2 { BORDER-RIGHT: #dddddd 1px solid; PADDING-RIGHT: 10px; BORDER-TOP: = #dddddd 1px solid; PADDING-LEFT: 12px; PADDING-BOTTOM: 8px; MARGIN: 3px = 0px; BORDER-LEFT: #dddddd 1px solid; PADDING-TOP: 8px; BORDER-BOTTOM: = #dddddd 1px solid; BACKGROUND-COLOR: #ffffff; TEXT-ALIGN: left } .box3 { BORDER-RIGHT: #cccccc 1px solid; PADDING-RIGHT: 10px; BORDER-TOP: = #cccccc 1px solid; PADDING-LEFT: 12px; PADDING-BOTTOM: 5px; MARGIN: 0px = 2px 3px; BORDER-LEFT: #cccccc 1px solid; PADDING-TOP: 1px; = BORDER-BOTTOM: #cccccc 1px solid; BACKGROUND-COLOR: #d2d2ff } .box4 { BORDER-RIGHT: #dddddd 1px solid; PADDING-RIGHT: 10px; BORDER-TOP: = #dddddd 1px solid; PADDING-LEFT: 12px; PADDING-BOTTOM: 20px; MARGIN: 0px = 2px 20px; BORDER-LEFT: #dddddd 1px solid; WIDTH: 220px; PADDING-TOP: = 1px; BORDER-BOTTOM: #dddddd 1px solid; BACKGROUND-COLOR: #ffffff } .fronttitles2 { PADDING-RIGHT: 10px; BORDER-TOP: #cee0e8 1px solid; PADDING-LEFT: 12px; = FONT-WEIGHT: bold; FONT-SIZE: 14px; BACKGROUND: = url(/images/background_tab2.jpg) #ffffff repeat-x left top; = MARGIN-BOTTOM: 10px; PADDING-BOTTOM: 20px; COLOR: #333333; PADDING-TOP: = 16px } .fronttitlesdate { FONT-WEIGHT: normal; FONT-SIZE: 12px; PADDING-TOP: 2px } .fronttitlesprevnext { FONT-WEIGHT: normal; FONT-SIZE: 12px; RIGHT: 7px; POSITION: relative; = TOP: 0px } .fronttitles { BORDER-RIGHT: #aaaaaa 1px solid; PADDING-RIGHT: 10px; BORDER-TOP: = #aaaaaa 1px solid; PADDING-LEFT: 10px; FONT-WEIGHT: bold; FONT-SIZE: = 14px; MARGIN-BOTTOM: 5px; PADDING-BOTTOM: 15px; BORDER-LEFT: #aaaaaa 1px = solid; COLOR: #333333; PADDING-TOP: 16px; BORDER-BOTTOM: #aaaaaa 1px = solid; BACKGROUND-COLOR: #e2edf1 } OPTION.option1 { BACKGROUND-COLOR: #f4f4ff } OPTION.option2 { BACKGROUND-COLOR: #ffffff } TEXTAREA { BORDER-RIGHT: #999999 1px solid; BORDER-TOP: #999999 1px solid; = FONT-SIZE: 12px; BORDER-LEFT: #999999 1px solid; BORDER-BOTTOM: #999999 = 1px solid; BACKGROUND-COLOR: #ffffff } A.menubutton1 { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: = #ffffff 1px solid; DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 11px; = PADDING-BOTTOM: 5px; BORDER-LEFT: #999999 1px solid; WIDTH: auto; = CURSOR: hand; COLOR: #0f4c78; PADDING-TOP: 5px; BORDER-BOTTOM: #999999 = 1px solid; HEIGHT: auto } A.menubutton2 { BORDER-RIGHT: #999999 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: = #ffffff 1px solid; DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 11px; = PADDING-BOTTOM: 5px; BORDER-LEFT: #999999 1px solid; WIDTH: auto; = CURSOR: hand; COLOR: #0f4c78; PADDING-TOP: 5px; BORDER-BOTTOM: #999999 = 1px solid; HEIGHT: auto } A.menubutton1:hover { BACKGROUND: #e2edf1 } A.menubutton2:hover { BACKGROUND: #e2edf1 } A.menubutton1 { BACKGROUND-COLOR: #ffffff } A.menubutton2 { BACKGROUND-COLOR: #faf9d3 } .menutitle { FONT-SIZE: 11px; BACKGROUND-REPEAT: no-repeat; FONT-FAMILY: Arial, = Helvetica, sans-serif } .menutitle2b { FONT-SIZE: 11px; BACKGROUND-REPEAT: no-repeat; FONT-FAMILY: Arial, = Helvetica, sans-serif } .menutitle { PADDING-RIGHT: 5px; PADDING-LEFT: 12px; BACKGROUND: = url(/images/menutitle.jpg) #002ab0 repeat-x; PADDING-BOTTOM: 5px; COLOR: = #ffffff; PADDING-TOP: 5px; TEXT-ALIGN: left } .articlecatlist { PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: = 0px; WIDTH: 150px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none } .articlecatlist LI { PADDING-BOTTOM: 1px; MARGIN: 0px; WIDTH: 148px; PADDING-TOP: 1px } .headertab1 { BORDER-RIGHT: #666666 1px solid; PADDING-RIGHT: 9px; BORDER-TOP: = #666666 1px solid; PADDING-LEFT: 8px; FONT-SIZE: 90%; BACKGROUND: = url(/images/background_tab.jpg) #ffffff repeat-x left top; = PADDING-BOTTOM: 9px; MARGIN: 0px 0px 10px; BORDER-LEFT: #666666 1px = solid; PADDING-TOP: 12px; BORDER-BOTTOM: #ffffff 1px solid; TEXT-ALIGN: = center } .headertab2 { BORDER-RIGHT: #aaaaaa 1px solid; PADDING-RIGHT: 5px; BORDER-TOP: = #aaaaaa 1px solid; PADDING-LEFT: 5px; FONT-SIZE: 90%; PADDING-BOTTOM: = 7px; MARGIN: 0px 0px 10px; BORDER-LEFT: #aaaaaa 1px solid; PADDING-TOP: = 7px; BORDER-BOTTOM: #aaaaaa 1px solid; BACKGROUND-COLOR: #eeeeee; = TEXT-ALIGN: center } ------=_NextPart_000_000B_01C993B4.19DEFBD0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.medicalnewstoday.com/scripts/AntiSpambotMailto.js /**************************************************** AntiSpambotMailto() - Documentation and encoder at: http://www.kenric.com/AntiSpambotMailto.html ****************************************************/ function AntiSpambotMailto(codelist, description, atagattr) { var thiscode, thischar; var CodeString =3D new String(codelist); var CodedArray =3D CodeString.split('|'); var L =3D CodedArray.length; var AddrDecoded =3D ""; for (var x=3D0; x < L; x++) { thiscode =3D CodedArray[x]; thischar =3D String.fromCharCode( thiscode - L ); AddrDecoded +=3D thischar; } atagattr =3D atagattr ? ' ' + atagattr : ''; if (!description) description =3D AddrDecoded; // if no description = supplied, display email address var strOutput =3D '' + description + ''; document.write(strOutput); } /************************************************************************= *** Copyright (c) 2002 by Kenric L. Ashe - www.kenric.com - All rights = reserved. Redistribution and use in source and binary forms, with or without=20 modification, are permitted provided that the following conditions are = met: Redistributions of source code must retain the above copyright notice,=20 this list of conditions and the following disclaimer.=20 Redistributions in binary form must reproduce the above copyright = notice,=20 this list of conditions and the following disclaimer in the = documentation=20 and/or other materials provided with the distribution.=20 Neither the name of the Kenric.com nor the names of its contributors may = be used to endorse or promote products derived from this software = without=20 specific prior written permission.=20 THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS=20 "AS IS" AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT=20 LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR=20 A PARTICULAR PURPOSE ARE DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT=20 OWNER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL,=20 SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED = TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR=20 PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF=20 LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING=20 NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS=20 SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. *************************************************************************= **/ ------=_NextPart_000_000B_01C993B4.19DEFBD0--